US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist

3.730
-0.190-4.85%

Close Aug 30 16:00 ET

3.730
0.0000.00%

Post 20:01 ET

3.12MMarket Cap0.00P/E (TTM)

Scinai Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-59.02%3.08M

-55.31%4.83M

-65.40%4.87M

-22.99%6.36M

-34.02%7.51M

-29.73%10.8M

-18.99%14.08M

-23.28%8.26M

-Cash and cash equivalents

-59.02%3.08M

-55.31%4.83M

-65.40%4.87M

-22.99%6.36M

-34.02%7.51M

-29.73%10.8M

-18.99%14.08M

-23.28%8.26M

Receivables

221.01%443K

142.02%288K

232.73%366K

13.97%228K

-23.46%138K

-38.85%119K

12.24%110K

-54.83%200.04K

-Accounts receivable

--119K

----

-Other receivables

134.78%324K

142.02%288K

232.73%366K

13.97%228K

-23.46%138K

-38.85%119K

12.24%110K

-54.83%200.04K

Prepaid assets

----

57.78%71K

----

-80.26%45K

----

Restricted cash

9.52%138K

10.24%140K

0.00%140K

--122K

--126K

--127K

-2.10%140K

----

Total current assets

-52.93%3.66M

-52.43%5.25M

-62.09%5.45M

-20.67%6.71M

-32.77%7.77M

-29.03%11.05M

-19.46%14.37M

-24.52%8.46M

Non current assets

Net PPE

-7.69%11.19M

-3.67%11.8M

-5.29%12.03M

-2.95%11.87M

-5.33%12.13M

-13.63%12.25M

-10.54%12.7M

-11.46%12.23M

-Gross PPE

-7.69%11.19M

-3.67%11.8M

-1.89%14.83M

-2.95%11.87M

-5.33%12.13M

-13.63%12.25M

-7.39%15.12M

-11.46%12.23M

-Accumulated depreciation

----

-15.99%-2.81M

----

-13.61%-2.42M

----

Other non current assets

----

96.08%271.59K

Total non current assets

-7.69%11.19M

-3.67%11.8M

-5.29%12.03M

-5.06%11.87M

-7.35%12.13M

-15.37%12.25M

-10.54%12.7M

-10.39%12.5M

Total assets

-25.36%14.85M

-26.79%17.05M

-35.45%17.47M

-11.36%18.58M

-19.27%19.9M

-22.45%23.29M

-15.51%27.07M

-16.69%20.96M

Liabilities

Current liabilities

Payables

-12.45%1.31M

-28.76%1.54M

-25.28%535K

27.05%1.16M

31.16%1.49M

-10.81%2.16M

-28.33%716K

-41.47%909.88K

-accounts payable

1.08%658K

-29.32%928K

-25.28%535K

84.64%546K

9.88%651K

1.82%1.31M

-28.33%716K

-71.26%295.72K

-Other payable

-22.89%650K

-27.90%610K

----

-0.68%610K

54.21%843K

-25.21%846K

----

16.81%614.16K

Current accrued expenses

----

-31.53%849K

----

15.89%1.24M

----

Current debt and capital lease obligation

-7.61%364K

-7.86%387K

3.66%396K

-31.96%382K

-93.01%394K

66.58%420K

1.87%382K

-97.23%561.42K

-Current debt

----

-98.79%242.13K

-Current capital lease obligation

-7.61%364K

-7.86%387K

3.66%396K

19.64%382K

59.63%394K

66.58%420K

1.87%382K

32.32%319.29K

Current liabilities

-11.44%1.67M

-25.36%1.93M

-23.87%1.78M

4.53%1.54M

-72.13%1.89M

-3.51%2.58M

-4.34%2.34M

-93.26%1.47M

Non current liabilities

Long term debt and capital lease obligation

-15.52%20.46M

-11.45%20.24M

-4.70%20.17M

15.35%19.43M

46.27%24.22M

2.74%22.86M

-26.04%21.16M

818.27%16.84M

-Long term debt

-14.91%19.82M

-10.71%19.51M

-3.56%19.37M

19.70%18.6M

55.66%23.29M

6.63%21.85M

-26.07%20.08M

--15.54M

-Long term capital lease obligation

-30.96%640K

-27.38%732K

-26.07%797K

-36.63%823K

-41.86%927K

-42.59%1.01M

-25.45%1.08M

-29.18%1.3M

Employee benefits

----

-9.66%26.65K

Derivative product liabilities

-99.67%3K

--0

-98.20%96K

--311K

--902K

--2.66M

--5.33M

----

Total non current liabilities

-18.54%20.46M

-20.69%20.24M

-23.51%20.26M

17.02%19.74M

51.47%25.12M

14.56%25.52M

-7.41%26.49M

726.88%16.87M

Total liabilities

-18.05%22.14M

-21.12%22.17M

-23.54%22.04M

16.01%21.27M

15.63%27.01M

12.63%28.1M

-7.17%28.83M

-23.15%18.34M

Shareholders'equity

Share capital

--0

-common stock

--0

Retained earnings

-3.01%-126.82M

-4.31%-124.49M

-5.61%-122.34M

-11.59%-120.01M

-10.44%-123.11M

-1.46%-119.35M

-5.27%-115.84M

2.19%-107.54M

Paid-in capital

3.00%121.27M

4.03%121.12M

2.95%119.51M

8.07%119.05M

4.42%117.74M

-5.12%116.43M

2.66%116.08M

-0.97%110.17M

Gains losses not affecting retained earnings

0.00%-1.74M

7.99%-1.74M

13.30%-1.74M

---1.74M

---1.89M

2.34%-2.01M

----

Total stockholders'equity

-2.42%-7.28M

-6.36%-5.12M

-159.60%-4.57M

-202.52%-2.69M

-652.67%-7.11M

-194.63%-4.81M

-279.23%-1.76M

101.99%2.63M

Total equity

-2.42%-7.28M

-6.36%-5.12M

-159.60%-4.57M

-202.52%-2.69M

-652.67%-7.11M

-194.63%-4.81M

-279.23%-1.76M

101.99%2.63M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-59.02%3.08M	-55.31%4.83M	-65.40%4.87M	-65.40%4.87M	-22.99%6.36M	-34.02%7.51M	-29.73%10.8M	-18.99%14.08M	-18.99%14.08M	-23.28%8.26M
-Cash and cash equivalents	-59.02%3.08M	-55.31%4.83M	-65.40%4.87M	-65.40%4.87M	-22.99%6.36M	-34.02%7.51M	-29.73%10.8M	-18.99%14.08M	-18.99%14.08M	-23.28%8.26M
Receivables	221.01%443K	142.02%288K	232.73%366K	232.73%366K	13.97%228K	-23.46%138K	-38.85%119K	12.24%110K	12.24%110K	-54.83%200.04K
-Accounts receivable	--119K	----	----	----	----	----	----	----	----	----
-Other receivables	134.78%324K	142.02%288K	232.73%366K	232.73%366K	13.97%228K	-23.46%138K	-38.85%119K	12.24%110K	12.24%110K	-54.83%200.04K
Prepaid assets	----	----	57.78%71K	57.78%71K	----	----	----	-80.26%45K	-80.26%45K	----
Restricted cash	9.52%138K	10.24%140K	0.00%140K	0.00%140K	--122K	--126K	--127K	-2.10%140K	-2.10%140K	----
Total current assets	-52.93%3.66M	-52.43%5.25M	-62.09%5.45M	-62.09%5.45M	-20.67%6.71M	-32.77%7.77M	-29.03%11.05M	-19.46%14.37M	-19.46%14.37M	-24.52%8.46M
Non current assets
Net PPE	-7.69%11.19M	-3.67%11.8M	-5.29%12.03M	-5.29%12.03M	-2.95%11.87M	-5.33%12.13M	-13.63%12.25M	-10.54%12.7M	-10.54%12.7M	-11.46%12.23M
-Gross PPE	-7.69%11.19M	-3.67%11.8M	-1.89%14.83M	-1.89%14.83M	-2.95%11.87M	-5.33%12.13M	-13.63%12.25M	-7.39%15.12M	-7.39%15.12M	-11.46%12.23M
-Accumulated depreciation	----	----	-15.99%-2.81M	-15.99%-2.81M	----	----	----	-13.61%-2.42M	-13.61%-2.42M	----
Other non current assets	----	----	----	----	----	----	----	----	----	96.08%271.59K
Total non current assets	-7.69%11.19M	-3.67%11.8M	-5.29%12.03M	-5.29%12.03M	-5.06%11.87M	-7.35%12.13M	-15.37%12.25M	-10.54%12.7M	-10.54%12.7M	-10.39%12.5M
Total assets	-25.36%14.85M	-26.79%17.05M	-35.45%17.47M	-35.45%17.47M	-11.36%18.58M	-19.27%19.9M	-22.45%23.29M	-15.51%27.07M	-15.51%27.07M	-16.69%20.96M
Liabilities
Current liabilities
Payables	-12.45%1.31M	-28.76%1.54M	-25.28%535K	-25.28%535K	27.05%1.16M	31.16%1.49M	-10.81%2.16M	-28.33%716K	-28.33%716K	-41.47%909.88K
-accounts payable	1.08%658K	-29.32%928K	-25.28%535K	-25.28%535K	84.64%546K	9.88%651K	1.82%1.31M	-28.33%716K	-28.33%716K	-71.26%295.72K
-Other payable	-22.89%650K	-27.90%610K	----	----	-0.68%610K	54.21%843K	-25.21%846K	----	----	16.81%614.16K
Current accrued expenses	----	----	-31.53%849K	-31.53%849K	----	----	----	15.89%1.24M	15.89%1.24M	----
Current debt and capital lease obligation	-7.61%364K	-7.86%387K	3.66%396K	3.66%396K	-31.96%382K	-93.01%394K	66.58%420K	1.87%382K	1.87%382K	-97.23%561.42K
-Current debt	----	----	----	----	----	----	----	----	----	-98.79%242.13K
-Current capital lease obligation	-7.61%364K	-7.86%387K	3.66%396K	3.66%396K	19.64%382K	59.63%394K	66.58%420K	1.87%382K	1.87%382K	32.32%319.29K
Current liabilities	-11.44%1.67M	-25.36%1.93M	-23.87%1.78M	-23.87%1.78M	4.53%1.54M	-72.13%1.89M	-3.51%2.58M	-4.34%2.34M	-4.34%2.34M	-93.26%1.47M
Non current liabilities
Long term debt and capital lease obligation	-15.52%20.46M	-11.45%20.24M	-4.70%20.17M	-4.70%20.17M	15.35%19.43M	46.27%24.22M	2.74%22.86M	-26.04%21.16M	-26.04%21.16M	818.27%16.84M
-Long term debt	-14.91%19.82M	-10.71%19.51M	-3.56%19.37M	-3.56%19.37M	19.70%18.6M	55.66%23.29M	6.63%21.85M	-26.07%20.08M	-26.07%20.08M	--15.54M
-Long term capital lease obligation	-30.96%640K	-27.38%732K	-26.07%797K	-26.07%797K	-36.63%823K	-41.86%927K	-42.59%1.01M	-25.45%1.08M	-25.45%1.08M	-29.18%1.3M
Employee benefits	----	----	----	----	----	----	----	----	----	-9.66%26.65K
Derivative product liabilities	-99.67%3K	--0	-98.20%96K	-98.20%96K	--311K	--902K	--2.66M	--5.33M	--5.33M	----
Total non current liabilities	-18.54%20.46M	-20.69%20.24M	-23.51%20.26M	-23.51%20.26M	17.02%19.74M	51.47%25.12M	14.56%25.52M	-7.41%26.49M	-7.41%26.49M	726.88%16.87M
Total liabilities	-18.05%22.14M	-21.12%22.17M	-23.54%22.04M	-23.54%22.04M	16.01%21.27M	15.63%27.01M	12.63%28.1M	-7.17%28.83M	-7.17%28.83M	-23.15%18.34M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-3.01%-126.82M	-4.31%-124.49M	-5.61%-122.34M	-5.61%-122.34M	-11.59%-120.01M	-10.44%-123.11M	-1.46%-119.35M	-5.27%-115.84M	-5.27%-115.84M	2.19%-107.54M
Paid-in capital	3.00%121.27M	4.03%121.12M	2.95%119.51M	2.95%119.51M	8.07%119.05M	4.42%117.74M	-5.12%116.43M	2.66%116.08M	2.66%116.08M	-0.97%110.17M
Gains losses not affecting retained earnings	0.00%-1.74M	7.99%-1.74M	13.30%-1.74M	13.30%-1.74M	---1.74M	---1.74M	---1.89M	2.34%-2.01M	2.34%-2.01M	----
Total stockholders'equity	-2.42%-7.28M	-6.36%-5.12M	-159.60%-4.57M	-159.60%-4.57M	-202.52%-2.69M	-652.67%-7.11M	-194.63%-4.81M	-279.23%-1.76M	-279.23%-1.76M	101.99%2.63M
Total equity	-2.42%-7.28M	-6.36%-5.12M	-159.60%-4.57M	-159.60%-4.57M	-202.52%-2.69M	-652.67%-7.11M	-194.63%-4.81M	-279.23%-1.76M	-279.23%-1.76M	101.99%2.63M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall